Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Human Chorionic Gonadotropin (HCG) Market Growth 2022-2028

  • LP 4853511
  • 103 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Human Chorionic Gonadotropin (HCG) will have significant change from previous year. According to our (LP Information) latest study, the global Human Chorionic Gonadotropin (HCG) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Chorionic Gonadotropin (HCG) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Human Chorionic Gonadotropin (HCG) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Chorionic Gonadotropin (HCG) market, reaching US$ million by the year 2028. As for the Europe Human Chorionic Gonadotropin (HCG) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Chorionic Gonadotropin (HCG) players cover EMD Serono, Inc, Ferring B.V, Merck & Co., Inc, and Bristol Myers Squibb Company, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Chorionic Gonadotropin (HCG) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Natural Source Extraction

Recombinant DNA Technology

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Female Infertility Treatment

Oligospermic Treatment

Cryptorchidism Treatment

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

EMD Serono, Inc

Ferring B.V

Merck & Co., Inc

Bristol Myers Squibb Company

Fresenius Kabi AG, LLC

Scrippslabs

Leebio

Kamiya Biomedical Company

Sanzyme

Cigna

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Chorionic Gonadotropin (HCG) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Chorionic Gonadotropin (HCG) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Chorionic Gonadotropin (HCG) by Country/Region, 2017, 2022 & 2028

2.2 Human Chorionic Gonadotropin (HCG) Segment by Type

2.2.1 Natural Source Extraction

2.2.2 Recombinant DNA Technology

2.3 Human Chorionic Gonadotropin (HCG) Sales by Type

2.3.1 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2022)

2.3.2 Global Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Chorionic Gonadotropin (HCG) Sale Price by Type (2017-2022)

2.4 Human Chorionic Gonadotropin (HCG) Segment by Application

2.4.1 Female Infertility Treatment

2.4.2 Oligospermic Treatment

2.4.3 Cryptorchidism Treatment

2.4.4 Others

2.5 Human Chorionic Gonadotropin (HCG) Sales by Application

2.5.1 Global Human Chorionic Gonadotropin (HCG) Sale Market Share by Application (2017-2022)

2.5.2 Global Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Chorionic Gonadotropin (HCG) Sale Price by Application (2017-2022)

3 Global Human Chorionic Gonadotropin (HCG) by Company

3.1 Global Human Chorionic Gonadotropin (HCG) Breakdown Data by Company

3.1.1 Global Human Chorionic Gonadotropin (HCG) Annual Sales by Company (2020-2022)

3.1.2 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Company (2020-2022)

3.2 Global Human Chorionic Gonadotropin (HCG) Annual Revenue by Company (2020-2022)

3.2.1 Global Human Chorionic Gonadotropin (HCG) Revenue by Company (2020-2022)

3.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Company (2020-2022)

3.3 Global Human Chorionic Gonadotropin (HCG) Sale Price by Company

3.4 Key Manufacturers Human Chorionic Gonadotropin (HCG) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Chorionic Gonadotropin (HCG) Product Location Distribution

3.4.2 Players Human Chorionic Gonadotropin (HCG) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Chorionic Gonadotropin (HCG) by Geographic Region

4.1 World Historic Human Chorionic Gonadotropin (HCG) Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Chorionic Gonadotropin (HCG) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Chorionic Gonadotropin (HCG) Annual Revenue by Geographic Region

4.2 World Historic Human Chorionic Gonadotropin (HCG) Market Size by Country/Region (2017-2022)

4.2.1 Global Human Chorionic Gonadotropin (HCG) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Chorionic Gonadotropin (HCG) Annual Revenue by Country/Region

4.3 Americas Human Chorionic Gonadotropin (HCG) Sales Growth

4.4 APAC Human Chorionic Gonadotropin (HCG) Sales Growth

4.5 Europe Human Chorionic Gonadotropin (HCG) Sales Growth

4.6 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Growth

5 Americas

5.1 Americas Human Chorionic Gonadotropin (HCG) Sales by Country

5.1.1 Americas Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022)

5.1.2 Americas Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022)

5.2 Americas Human Chorionic Gonadotropin (HCG) Sales by Type

5.3 Americas Human Chorionic Gonadotropin (HCG) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Chorionic Gonadotropin (HCG) Sales by Region

6.1.1 APAC Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2022)

6.1.2 APAC Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2022)

6.2 APAC Human Chorionic Gonadotropin (HCG) Sales by Type

6.3 APAC Human Chorionic Gonadotropin (HCG) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Chorionic Gonadotropin (HCG) by Country

7.1.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022)

7.1.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022)

7.2 Europe Human Chorionic Gonadotropin (HCG) Sales by Type

7.3 Europe Human Chorionic Gonadotropin (HCG) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) by Country

8.1.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Type

8.3 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Chorionic Gonadotropin (HCG)

10.3 Manufacturing Process Analysis of Human Chorionic Gonadotropin (HCG)

10.4 Industry Chain Structure of Human Chorionic Gonadotropin (HCG)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Chorionic Gonadotropin (HCG) Distributors

11.3 Human Chorionic Gonadotropin (HCG) Customer

12 World Forecast Review for Human Chorionic Gonadotropin (HCG) by Geographic Region

12.1 Global Human Chorionic Gonadotropin (HCG) Market Size Forecast by Region

12.1.1 Global Human Chorionic Gonadotropin (HCG) Forecast by Region (2023-2028)

12.1.2 Global Human Chorionic Gonadotropin (HCG) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Chorionic Gonadotropin (HCG) Forecast by Type

12.7 Global Human Chorionic Gonadotropin (HCG) Forecast by Application

13 Key Players Analysis

13.1 EMD Serono, Inc

13.1.1 EMD Serono, Inc Company Information

13.1.2 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Offered

13.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 EMD Serono, Inc Main Business Overview

13.1.5 EMD Serono, Inc Latest Developments

13.2 Ferring B.V

13.2.1 Ferring B.V Company Information

13.2.2 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Offered

13.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ferring B.V Main Business Overview

13.2.5 Ferring B.V Latest Developments

13.3 Merck & Co., Inc

13.3.1 Merck & Co., Inc Company Information

13.3.2 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Offered

13.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck & Co., Inc Main Business Overview

13.3.5 Merck & Co., Inc Latest Developments

13.4 Bristol Myers Squibb Company

13.4.1 Bristol Myers Squibb Company Company Information

13.4.2 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Offered

13.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bristol Myers Squibb Company Main Business Overview

13.4.5 Bristol Myers Squibb Company Latest Developments

13.5 Fresenius Kabi AG, LLC

13.5.1 Fresenius Kabi AG, LLC Company Information

13.5.2 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Offered

13.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Fresenius Kabi AG, LLC Main Business Overview

13.5.5 Fresenius Kabi AG, LLC Latest Developments

13.6 Scrippslabs

13.6.1 Scrippslabs Company Information

13.6.2 Scrippslabs Human Chorionic Gonadotropin (HCG) Product Offered

13.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Scrippslabs Main Business Overview

13.6.5 Scrippslabs Latest Developments

13.7 Leebio

13.7.1 Leebio Company Information

13.7.2 Leebio Human Chorionic Gonadotropin (HCG) Product Offered

13.7.3 Leebio Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Leebio Main Business Overview

13.7.5 Leebio Latest Developments

13.8 Kamiya Biomedical Company

13.8.1 Kamiya Biomedical Company Company Information

13.8.2 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Offered

13.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Kamiya Biomedical Company Main Business Overview

13.8.5 Kamiya Biomedical Company Latest Developments

13.9 Sanzyme

13.9.1 Sanzyme Company Information

13.9.2 Sanzyme Human Chorionic Gonadotropin (HCG) Product Offered

13.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sanzyme Main Business Overview

13.9.5 Sanzyme Latest Developments

13.10 Cigna

13.10.1 Cigna Company Information

13.10.2 Cigna Human Chorionic Gonadotropin (HCG) Product Offered

13.10.3 Cigna Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Cigna Main Business Overview

13.10.5 Cigna Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Human Chorionic Gonadotropin (HCG) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Chorionic Gonadotropin (HCG) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Natural Source Extraction

Table 4. Major Players of Recombinant DNA Technology

Table 5. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)

Table 6. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2022)

Table 7. Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2022)

Table 9. Global Human Chorionic Gonadotropin (HCG) Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)

Table 11. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2022)

Table 12. Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022)

Table 13. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2022)

Table 14. Global Human Chorionic Gonadotropin (HCG) Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Human Chorionic Gonadotropin (HCG) Sales by Company (2020-2022) & (K Units)

Table 16. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Company (2020-2022)

Table 17. Global Human Chorionic Gonadotropin (HCG) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Company (2020-2022)

Table 19. Global Human Chorionic Gonadotropin (HCG) Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Human Chorionic Gonadotropin (HCG) Producing Area Distribution and Sales Area

Table 21. Players Human Chorionic Gonadotropin (HCG) Products Offered

Table 22. Human Chorionic Gonadotropin (HCG) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Human Chorionic Gonadotropin (HCG) Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Human Chorionic Gonadotropin (HCG) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Human Chorionic Gonadotropin (HCG) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Human Chorionic Gonadotropin (HCG) Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Human Chorionic Gonadotropin (HCG) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)

Table 34. Americas Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2017-2022)

Table 35. Americas Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2017-2022)

Table 37. Americas Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)

Table 38. Americas Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2022)

Table 39. Americas Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)

Table 40. Americas Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2022)

Table 41. APAC Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2022) & (K Units)

Table 42. APAC Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2017-2022)

Table 43. APAC Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2017-2022)

Table 45. APAC Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)

Table 46. APAC Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2022)

Table 47. APAC Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)

Table 48. APAC Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2022)

Table 49. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)

Table 50. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2017-2022)

Table 51. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2017-2022)

Table 53. Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)

Table 54. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2022)

Table 55. Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)

Table 56. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Human Chorionic Gonadotropin (HCG)

Table 66. Key Market Challenges & Risks of Human Chorionic Gonadotropin (HCG)

Table 67. Key Industry Trends of Human Chorionic Gonadotropin (HCG)

Table 68. Human Chorionic Gonadotropin (HCG) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Human Chorionic Gonadotropin (HCG) Distributors List

Table 71. Human Chorionic Gonadotropin (HCG) Customer List

Table 72. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Human Chorionic Gonadotropin (HCG) Sales Market Forecast by Region

Table 74. Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Human Chorionic Gonadotropin (HCG) Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Human Chorionic Gonadotropin (HCG) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Human Chorionic Gonadotropin (HCG) Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Human Chorionic Gonadotropin (HCG) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Human Chorionic Gonadotropin (HCG) Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Human Chorionic Gonadotropin (HCG) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share Forecast by Application (2023-2028)

Table 92. EMD Serono, Inc Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 93. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Offered

Table 94. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. EMD Serono, Inc Main Business

Table 96. EMD Serono, Inc Latest Developments

Table 97. Ferring B.V Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 98. Ferring B.V Human Chorionic Gonadotropin (HCG) Product Offered

Table 99. Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Ferring B.V Main Business

Table 101. Ferring B.V Latest Developments

Table 102. Merck & Co., Inc Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 103. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Offered

Table 104. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Merck & Co., Inc Main Business

Table 106. Merck & Co., Inc Latest Developments

Table 107. Bristol Myers Squibb Company Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 108. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Offered

Table 109. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Bristol Myers Squibb Company Main Business

Table 111. Bristol Myers Squibb Company Latest Developments

Table 112. Fresenius Kabi AG, LLC Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 113. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Offered

Table 114. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Fresenius Kabi AG, LLC Main Business

Table 116. Fresenius Kabi AG, LLC Latest Developments

Table 117. Scrippslabs Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 118. Scrippslabs Human Chorionic Gonadotropin (HCG) Product Offered

Table 119. Scrippslabs Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Scrippslabs Main Business

Table 121. Scrippslabs Latest Developments

Table 122. Leebio Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 123. Leebio Human Chorionic Gonadotropin (HCG) Product Offered

Table 124. Leebio Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Leebio Main Business

Table 126. Leebio Latest Developments

Table 127. Kamiya Biomedical Company Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 128. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Offered

Table 129. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Kamiya Biomedical Company Main Business

Table 131. Kamiya Biomedical Company Latest Developments

Table 132. Sanzyme Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 133. Sanzyme Human Chorionic Gonadotropin (HCG) Product Offered

Table 134. Sanzyme Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Sanzyme Main Business

Table 136. Sanzyme Latest Developments

Table 137. Cigna Basic Information, Human Chorionic Gonadotropin (HCG) Manufacturing Base, Sales Area and Its Competitors

Table 138. Cigna Human Chorionic Gonadotropin (HCG) Product Offered

Table 139. Cigna Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Cigna Main Business

Table 141. Cigna Latest Developments

List of Figures

Figure 1. Picture of Human Chorionic Gonadotropin (HCG)

Figure 2. Human Chorionic Gonadotropin (HCG) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Chorionic Gonadotropin (HCG) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Natural Source Extraction

Figure 10. Product Picture of Recombinant DNA Technology

Figure 11. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type in 2021

Figure 12. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2022)

Figure 13. Human Chorionic Gonadotropin (HCG) Consumed in Female Infertility Treatment

Figure 14. Global Human Chorionic Gonadotropin (HCG) Market: Female Infertility Treatment (2017-2022) & (K Units)

Figure 15. Human Chorionic Gonadotropin (HCG) Consumed in Oligospermic Treatment

Figure 16. Global Human Chorionic Gonadotropin (HCG) Market: Oligospermic Treatment (2017-2022) & (K Units)

Figure 17. Human Chorionic Gonadotropin (HCG) Consumed in Cryptorchidism Treatment

Figure 18. Global Human Chorionic Gonadotropin (HCG) Market: Cryptorchidism Treatment (2017-2022) & (K Units)

Figure 19. Human Chorionic Gonadotropin (HCG) Consumed in Others

Figure 20. Global Human Chorionic Gonadotropin (HCG) Market: Others (2017-2022) & (K Units)

Figure 21. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2022)

Figure 22. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application in 2021

Figure 23. Human Chorionic Gonadotropin (HCG) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Company in 2021

Figure 25. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2017-2022)

Figure 28. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Human Chorionic Gonadotropin (HCG) Sales 2017-2022 (K Units)

Figure 30. Americas Human Chorionic Gonadotropin (HCG) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Human Chorionic Gonadotropin (HCG) Sales 2017-2022 (K Units)

Figure 32. APAC Human Chorionic Gonadotropin (HCG) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Human Chorionic Gonadotropin (HCG) Sales 2017-2022 (K Units)

Figure 34. Europe Human Chorionic Gonadotropin (HCG) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Human Chorionic Gonadotropin (HCG) Sales Market Share by Country in 2021

Figure 38. Americas Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country in 2021

Figure 39. United States Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Human Chorionic Gonadotropin (HCG) Sales Market Share by Region in 2021

Figure 44. APAC Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions in 2021

Figure 45. China Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Country in 2021

Figure 52. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country in 2021

Figure 53. Germany Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country in 2021

Figure 60. Egypt Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Human Chorionic Gonadotropin (HCG) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Human Chorionic Gonadotropin (HCG) in 2021

Figure 66. Manufacturing Process Analysis of Human Chorionic Gonadotropin (HCG)

Figure 67. Industry Chain Structure of Human Chorionic Gonadotropin (HCG)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390